Project Grant F30DA060666
Award Date
9/13/24
Completion Date
4/30/28
Dollars Obligated
$267K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Miami, FL 33136, USA
Similar Awards
This $373,181 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to investigate the role of cholinergic interneurons in the ventral tegmental area on opioid-related behaviors. The key objectives are to determine whether mu-opioid receptors on cholinergic interneurons participate in opioid reward, consumption, and withdrawal, and whether these receptors regulate dopamine release during these...
The $858,600 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to identify and validate G protein-coupled receptors (GPCRs) expressed by somatostatin-expressing inhibitory neurons in the prefrontal cortex as potential targets for developing novel treatments for opioid use disorder (OUD). The research aims to take an unbiased transcriptomics approach to identify GPCR transcripts in these...
This federal Project Grant award for $362,080, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of the anterior cingulate cortex (ACC) and its connections to the spinal cord in the development of associative opioid analgesic tolerance. The goal is to uncover the neuronal mechanisms underlying this phenomenon, which can lead to opioid use disorder and overdoses. The research will...
This federal Project Grant award of $159,711 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research aimed at uncovering the neurophysiological signatures related to acute opioid use within the brain's addiction circuitry. The principal investigator, Dr. Ryu, will leverage a unique opportunity to directly record neural signals from deep brain regions in awake human patients to assess changes in connectivity within...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $149,284 to the University of Washington to investigate the role of specific neuron subpopulations in the prefrontal cortex in regulating drug-seeking behavior. The project aims to use combinatorial viral approaches and techniques like fiber photometry and chemogenetics to characterize how chronic heroin self-administration alters the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $601,612 to the Icahn School of Medicine at Mount Sinai to conduct research on the neural mechanisms underlying opioid tolerance and withdrawal. The research aims to use molecular profiling, viral approaches, and behavioral analysis in mice to examine gene expression and neuronal activity changes in the habenula-interpeduncular nucleus circuit in...
The National Institute on Drug Abuse (NIDA) awarded a $1,039,420 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Medical University of South Carolina (MUSC). The 5-year grant, running from June 1, 2025 to February 28, 2030, will support research aimed at characterizing the transcriptomic profiles and causal functions of specific neuronal ensembles within key brain circuits that govern the facilitation and disinhibition of alcohol and opioid seeking...
The National Institute on Drug Abuse (NIDA) awarded a $847,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Tennessee Health Science Center in Memphis, TN. The grant, titled "Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse", aims to investigate the therapeutic potential of the neuropeptide S receptor 1 (NPSR1) in treating opioid use disorder. The research team will leverage...
This National Institute on Drug Abuse (NIDA) Project Grant Award under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $154,568 to The Washington University in St. Louis to investigate the role of enkephalin neurons in the dorsal raphe nucleus on motivational and affective behaviors during chronic pain. The research aims to use dual-color imaging, chemogenetic manipulations, and viral gene editing techniques to determine how these opioid-containing neurons contribute to the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $147,656.00 to Emory University to examine the modulatory role of galanin in opioid reward. The award period is from February 1, 2025, to August 31, 2027. The project will investigate the neurobiological mechanisms underlying the interaction between the galanin and opioid systems, with the goal of developing a better understanding of the...